Skip to main content
Clinical Trials/NCT04009538
NCT04009538
Completed
Not Applicable

The Effect of Re-Rehabilitation in Patients With COPD

Izmir Katip Celebi University0 sites22 target enrollmentJanuary 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Copd
Sponsor
Izmir Katip Celebi University
Enrollment
22
Primary Endpoint
Exercise Capacity
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Detailed Description

Pulmonary rehabilitation (PR) program in patients with COPD reduces dyspnea perception, increases exercise capacity, improves quality of life, and reduces psychological symptoms. Unfortunately, these gains are not permanent, but disappear within 12-24 months. The aim of this study is to compare the gains of the second PR program with the first program. Patients with COPD who participated in the second rehabilitation program in the Pulmonary Rehabilitation unit will be included in the study. Pulmonary function tests, arterial blood gases, mMRC dyspnea perception, 6-minute walking distance, disease-specific (SGRQ) quality of life and hospital anxiety depression scale values will be compared.

Registry
clinicaltrials.gov
Start Date
January 2013
End Date
March 2019
Last Updated
6 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Izmir Katip Celebi University
Responsible Party
Principal Investigator
Principal Investigator

Ilknur Naz

Asst. Prof.

Izmir Katip Celebi University

Eligibility Criteria

Inclusion Criteria

  • Above 18 years
  • Completed PR program

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Exercise Capacity

Time Frame: 6 minutes

Six minutes walk test

Secondary Outcomes

  • Respiratory Functions(30 minutes)
  • Dyspnea Sensation(5 minutes)
  • Disease Specific Quality of Life(20 minutes)
  • Anxiety and Depression(20 minutes)

Similar Trials